Clinical Trial Update: Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of BCG for preventing postoperative recurrence in medium/high-risk non-muscle invasive bladder cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Chengdu CoenBiotech Co., Ltd | Conditions: Non-Muscle Invasive Bladder Cancer | Phase 3 | Status: RECRUITING